Skip to main content
MyPeptideMatch
Reviewed by MyPeptideMatch Editorial TeamLast reviewed October 2026Updated October 2026

Pinealon Dosing Protocol: 20 mg Vial, Reconstitution & Units

Pinealon (Glu-Asp-Arg tripeptide) bioregulator: community-reported dosing, reconstitution math for the 20 mg vial, and what the research does and doesn't support.

Quickstart highlights

Pinealon is the synthetic tripeptide Glu-Asp-Arg (EDR), developed by Vladimir Khavinson's group in St.

  • No dose has been established by a controlled trial. The injectable amounts on this page are community-reported.
  • The only human dose in PubMed is oral: one 100 µg capsule twice daily for two weeks, in a small Russian open study.
  • For the commonly quoted 200 µg: 20 mg vial + 10 mL bac water = 2 mg/mL, so 200 µg = 10 units.
  • At 200 µg per dose, one 20 mg vial holds 100 doses.
  • The research behind Pinealon is mostly cell and rodent work. See the Pinealon peptide page for the evidence.

Dosing table

For educational reference only. Your prescribing provider may adjust doses based on your clinical profile and response.

WeekDose (µg)UnitsFrequencyNotes
1-220010Once dailyCommunity-reported, not from a trial; 200 µg = 10 units at 2 mg/mL; one 20 mg vial holds 100 doses at this amount
maintenance20010Every other dayCommunity-reported, not from a trial; no study has tested a maintenance schedule or long-term use

Your free Pinealon tracker

  • Dose reminders
  • Injection logging
  • Cycle progress
Create free account Already have one? Sign in

Reconstitution steps

  1. Draw 10 mL bacteriostatic water in four 2.5 mL draws; inject slowly down the vial wall.
  2. Swirl gently until powder dissolves; do not shake.
  3. Final concentration: 2 mg/mL (20 mg / 10 mL). At 2 mg/mL: 200 µg = 10 units.
  4. Label with date; refrigerate at 2–8 °C. Use within 28 days. Reconstitute in 2.5 mL portions if desired.

Supplies needed

12_wk-week plan

  • 1 vial
  • 42 syringes
  • 10 mL bac water
  • 42 alcohol swabs

10_day-week plan

  • 1 vial
  • 10 syringes
  • 10 mL bac water
  • 10 alcohol swabs
Need clinics? See vetted providers →

Protocol overview & cycle notes

Reference schedule and reconstitution math for a 20 mg Pinealon vial. Pinealon has cell and rodent research on neuroprotection and small Russian human reports, but no controlled trials, so the injectable amounts on this page are community-reported, not clinically established.

Off-cycle: Not established. Community sources describe breaks of several weeks between courses; no study has tested cycle length. The only human course in PubMed lasted two weeks.

Storage & handling

Lyophilized: store below 25 °C, away from light. Reconstituted at 2 mg/mL: refrigerate at 2–8 °C and use within 28 days. At 200 µg per dose, one 20 mg vial holds 100 doses.

Injection & tracking tips

  • Community protocols describe subcutaneous injection into abdominal or thigh fat; no study has compared routes or timing of day.
  • Rotate injection sites and use a new sterile syringe every time.
  • No study has tested this peptide combined with any other peptide, so combination protocols are untested.
  • Pinealon has no systematic human safety data. If you have a neurological condition, a blood disorder or cancer, keep your physician involved.

Tracking

Logging helps you and your provider spot patterns and adjust dose or timing.

  • Record the start date, amount, product lot and certificate of analysis for each course.
  • If you track sleep or cognition, use a validated scale (for example the PSQI for sleep) before and after the course; no study has tested Pinealon on either.
  • Note any side effects, including injection-site reactions, and share them with your physician.
Log your cycle in the calculator →

How this works & references

Pinealon is the synthetic tripeptide Glu-Asp-Arg (EDR), developed by Vladimir Khavinson's group in St. Petersburg as a neuroprotective "bioregulator." In cell studies it reduced reactive oxygen species and necrotic death in neurons, and in mice with an Alzheimer's disease model, 400 µg/kg daily for two months modestly increased hippocampal dendritic spine density. Despite the name, a pineal gland cell culture study found no effect on pineal cells, and no study has measured melatonin or sleep. Human data is limited to small Russian open studies, and most of the research comes from Khavinson's network without independent replication.

Frequently asked questions

What is the Pinealon dosage per day?
No dose has been established by a controlled trial. The only human dose in PubMed is oral: one 100 µg capsule twice a day (200 µg a day) for two weeks, in a small Russian study of train crew workers. Community-reported amounts for injectable vials are often around 200 µg once daily. Treat all of these as unverified.
How do I reconstitute a 10 mg or 20 mg Pinealon vial?
The math depends on the concentration you want. A 20 mg vial plus 10 mL bacteriostatic water gives 2 mg/mL, where 200 µg = 10 units on a U-100 insulin syringe. A 10 mg vial plus 5 mL gives the same 2 mg/mL. Vial size changes how many doses you get, not what dose is appropriate.
When is the best time to take Pinealon, and does it help sleep?
No study has compared morning and evening dosing or measured Pinealon's effect on sleep or melatonin. Evening timing is often suggested online because of the 'pineal' name, but in a pineal gland cell culture study, Pinealon did not stimulate pineal cells.
How long is a Pinealon cycle?
Cycle length has not been studied. Community protocols describe courses from 10 days to several weeks with breaks in between. The only human course in PubMed lasted two weeks.
Can Pinealon be taken orally or as a nasal spray?
Oral capsules are the only form used in published human studies. We found no published study of Pinealon nasal spray, and no human pharmacokinetic data for any route, so bioavailability and half-life are unknown.
What are the side effects of Pinealon?
There is no systematic human safety data. One small Russian study in 32 older patients reported a pro-oxidant effect and a fall in CD34+ blood stem cell markers. Injected research vials also carry risks of site reactions, contamination and uncertain purity.

Related protocols

This content is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting any peptide therapy. Dosing and protocols may vary by formulation and prescriber.